![Table 2 from Comparison of NAFLD fibrosis score and BARD score in predicting fibrosis in nonalcoholic fatty liver disease. | Semantic Scholar Table 2 from Comparison of NAFLD fibrosis score and BARD score in predicting fibrosis in nonalcoholic fatty liver disease. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/f6107ba73a629655bcdfe997cab20b8465c95424/3-Table2-1.png)
Table 2 from Comparison of NAFLD fibrosis score and BARD score in predicting fibrosis in nonalcoholic fatty liver disease. | Semantic Scholar
![The FibroScan-aspartate aminotransferase score can stratify the disease severity in a Japanese cohort with fatty liver diseases | Scientific Reports The FibroScan-aspartate aminotransferase score can stratify the disease severity in a Japanese cohort with fatty liver diseases | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-021-93435-x/MediaObjects/41598_2021_93435_Fig2_HTML.png)
The FibroScan-aspartate aminotransferase score can stratify the disease severity in a Japanese cohort with fatty liver diseases | Scientific Reports
![Table 2 from Comparison of NAFLD fibrosis score and BARD score in predicting fibrosis in nonalcoholic fatty liver disease. | Semantic Scholar Table 2 from Comparison of NAFLD fibrosis score and BARD score in predicting fibrosis in nonalcoholic fatty liver disease. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/f6107ba73a629655bcdfe997cab20b8465c95424/2-Table1-1.png)
Table 2 from Comparison of NAFLD fibrosis score and BARD score in predicting fibrosis in nonalcoholic fatty liver disease. | Semantic Scholar
![Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020 | SpringerLink Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020 | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00535-021-01796-x/MediaObjects/535_2021_1796_Fig1_HTML.png)
Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020 | SpringerLink
![Table 1 from The BARD score and the NAFLD fibrosis score in the assessment of advanced liver fibrosis in nonalcoholic fatty liver disease | Semantic Scholar Table 1 from The BARD score and the NAFLD fibrosis score in the assessment of advanced liver fibrosis in nonalcoholic fatty liver disease | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/b90b27221a866f1a2786f6986421c23611d0efdf/3-Table1-1.png)
Table 1 from The BARD score and the NAFLD fibrosis score in the assessment of advanced liver fibrosis in nonalcoholic fatty liver disease | Semantic Scholar
![Non-invasive scoring systems for predicting NASH in Japan: evidences from Japan Study Group of NAFLD Non-invasive scoring systems for predicting NASH in Japan: evidences from Japan Study Group of NAFLD](https://www.oatext.com/img/Non-invasive-3.jpg)
Non-invasive scoring systems for predicting NASH in Japan: evidences from Japan Study Group of NAFLD
The Development of the Pediatric NAFLD Fibrosis Score (PNFS) to Predict the Presence of Advanced Fibrosis in Children with Nonalcoholic Fatty Liver Disease | PLOS ONE
![The NAFLD Decompensation Risk Score: External Validation and Comparison to Existing Models to Predict Hepatic Events in a Retrospective Cohort Study - ScienceDirect The NAFLD Decompensation Risk Score: External Validation and Comparison to Existing Models to Predict Hepatic Events in a Retrospective Cohort Study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0973688322005163-ga1.jpg)